Use of Methylene Blue in Refractory Anaphylaxis May Prevent a Catastrophic Intubation

Pemmaraju, D.; Kallur, Lakshmi; Roach, Kristopher; King, Alexandra; Bryant, Kathleen; Lindsey, J. Suzanne; Sahebazamani, Mitra

doi:10.1016/j.chest.2019.08.1634

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The literature describes case reports where methylene blue has been used in refractory shock states after the standard anaphylactic shock management failed [44][45][46][47][48][49][50]. In the majority of these cases, the hypotension resolved within 20 min [47].…”

Section: Discussionmentioning

confidence: 99%

Effect of Nitric Oxide Pathway Inhibition on the Evolution of Anaphylactic Shock in Animal Models: A Systematic Review

Alfalasi

Alzaabi

Östlundh

et al. 2022

Biology

View full text Add to dashboard Cite

Nitric oxide (NO) induces vasodilation in various types of shock. The effect of pharmacological modulation of the NO pathway in anaphylactic shock (AS) remains poorly understood. Our objective was to assess, through a systematic review, whether inhibition of NO pathways (INOP) was beneficial for the prevention and/or treatment of AS. A predesigned protocol for this systematic review was published in PROSPERO (CRD42019132273). A systematic literature search was conducted till March 2022 in the electronic databases PubMed, EMBASE, Scopus, Cochrane and Web of Science. Heterogeneity of the studies did not allow meta-analysis. Nine hundred ninety unique studies were identified. Of 135 studies screened in full text, 17 were included in the review. Among six inhibitors of NO pathways identified, four blocked NO synthase activity and two blocked guanylate cyclase downstream activity. Pre-treatment was used in nine studies and post-treatment in three studies. Five studies included both pre-treatment and post-treatment models. Overall, seven pre-treatment studies from fourteen showed improvement of survival and/or arterial blood pressure. Four post-treatment studies from eight showed positive outcomes. Overall, there was no strong evidence to conclude that isolated blockade of the NO/cGMP pathway is sufficient to prevent or restore anaphylactic hypotension. Further studies are needed to analyze the effect of drug combinations in the treatment of AS.

show abstract